KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.6026
-0.0724 (-10.73%)
At close: Jan 20, 2026, 4:00 PM EST
0.6170
+0.0144 (2.39%)
Pre-market: Jan 21, 2026, 5:15 AM EST
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $17.02 million as of January 21, 2026. Its market cap has decreased by -52.05% in one year.
Market Cap
17.02M
Enterprise Value
25.87M
1-Year Change
-52.05%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $17.02M, a decrease of -96.05%. That is a compound annual growth rate of -31.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 5.00M | 8.70% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lisata Therapeutics | 19.05M |
| CollPlant Biotechnologies | 18.78M |
| OSR Holdings | 18.45M |
| Lexaria Bioscience | 18.31M |
| Kairos Pharma | 18.21M |
| ProMIS Neurosciences | 17.57M |
| Iterum Therapeutics | 17.40M |
| Cadrenal Therapeutics | 17.23M |